Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/1525
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShorie, Munish-
dc.contributor.authorSabherwal, Priyanka-
dc.contributor.authorGhosh, Deepa-
dc.date.accessioned2021-12-08T11:28:15Z-
dc.date.available2021-12-08T11:28:15Z-
dc.date.issued2021-07-28-
dc.identifier.urihttp://hdl.handle.net/123456789/1525-
dc.description.abstractThe research work in this thesis deals with the thorough investigation of various sensing approaches to develop an advanced aptasensing platform for the diagnosis of cardiovascular diseases, by targeting specific serum biomarkers (i) Myoglobin (ii) B-type Natriuretic Peptide (iii) Troponin I. In this study, DNA aptamers were chosen as the bioreceptors and different transducers were comparatively investigated to find the best candidate for the monitoring of cardiac diseases. For the generation of DNA aptamers, advanced variants of its generation method named Microtitre plate-SELEX & BLI-SELEX were developed and used to generate aptamers against Myoglobin, Troponin I & BNP. A plethora of nanomaterials & composites were synthesized to act as ultra-sensitive transducers for the biosensors, and a comparative analysis of fluorescence, electrochemical & Raman-based biosensors was performed for the detection of selected cardiac markers using their specific aptamers. The field applicability of the fluorescence-based platform was exploited by developing it into a smartphone based point-of-care device for myoglobin. Electrochemical transducers were found to be most suitable due to their wide range of detection (1pg/mL – 16 μg/mL on phosphorene-modified sensor), and ease of operation & field applicability, although Raman- based platform produced the lowest detection limit (10 fg/mL – 0.1 μg/mL on AuNP decorated WS 2 nanosheets). Based on this, a WSe 2 nanosheets based impedimetric biosensor was developed for the detection of B-type natriuretic peptide (0.1 ng/mL – 10 μg/mL). Finally, photolithographic microfabrication was used to develop a microfluidics device based on a dual cellular separation mechanism. The device showed remarkable ability of cellular separation (~99%) from whole/diluted blood samples, and was further developed into a multiplex device. The device was demonstrated for its multiplexing abilities for the simultaneous detection of myoglobin (1 ng/mL – 1 μg/mL) and troponin I (10 pg/mL – 10 ng/mL).en_US
dc.language.isoenen_US
dc.publisherIISERMen_US
dc.subjectNanobioprobeen_US
dc.subjectCardiovascular diseasesen_US
dc.titleAptamer functionalized nanobioprobe based sensing platforms for cardiovascular diseasesen_US
dc.typeThesisen_US
Appears in Collections:PhD-2014

Files in This Item:
File Description SizeFormat 
PH14213.odt18.7 kBOpenDocument TextView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.